The Alzheimer's a new hope

2002/11/01 Elhuyar Zientzia Iturria: Elhuyar aldizkaria

• Osasuna

Last March we learned that they abandoned vaccine tests to cure Alzheimer's. Despite the good results in animals, in humans, 15 out of 360 patients suffered an inflammation in the brain. Later we have known that this inflammation was a collateral effect, but that the vaccine fulfilled its function: the vaccine produces antibodies against beta-amyloid proteins that accumulate in the brain and also does not affect the rest of beta-amyloid proteins.

The vaccine, called AN-1792, contains agents to attach immune response cells to the protein such as synthetic beta-amyloids that appear on platelets.

Although they do not know the causes that caused inflammation in patients, different alternatives and solutions are being studied.